Related Experiment Video
Updated: May 4, 2026

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay
Published on: March 10, 2015
Molecular barriers to zoonotic transmission of prions
Abstract:
The risks posed to human health by individual animal prion diseases cannot be determined a priori and are difficult to address empirically. The fundamental event in prion disease pathogenesis is thought to be the seeded conversion of normal prion protein to its pathologic isoform. We used a rapid molecular conversion assay (protein misfolding cyclic amplification) to test whether brain homogenates from specimens of classical bovine spongiform encephalopathy (BSE), atypical BSE (H-type BSE and L-type BSE), classical scrapie, atypical scrapie, and chronic wasting disease can convert normal human prion protein to the abnormal disease-associated form. None of the tested prion isolates from diseased animals were as efficient as classical BSE in converting human prion protein. However, in the case of chronic wasting disease, there was no absolute barrier to conversion of the human prion protein.
Insights
Animal prion diseases pose risks to human health. Research shows chronic wasting disease prions can convert human prion protein, indicating a potential public health concern.
Area of Science:
- Neuroscience
- Infectious Diseases
- Molecular Biology
Background:
- Prion diseases are fatal neurodegenerative disorders.
- The conversion of normal prion protein (PrP) to its misfolded isoform is central to prion disease pathogenesis.
- Assessing the zoonotic risk of animal prion diseases is challenging.
Purpose of the Study:
- To evaluate the potential of various animal prion diseases to infect humans.
- To determine if different animal prion strains can convert human prion protein (HuPrP).
Main Methods:
- Utilized the protein misfolding cyclic amplification (PMCA) assay, a rapid molecular conversion technique.
- Tested brain homogenates from animals with classical bovine spongiform encephalopathy (BSE), atypical BSE (H-type and L-type), classical scrapie, atypical scrapie, and chronic wasting disease (CWD).
- Assessed the efficiency of these animal prion isolates in converting normal human prion protein.
Main Results:
- Classical BSE was the most efficient in converting human prion protein among the tested isolates.
- While less efficient than classical BSE, chronic wasting disease isolates demonstrated a potential for human prion protein conversion.
- No absolute barrier was observed for chronic wasting disease in converting human prion protein.
Conclusions:
- The study highlights the potential zoonotic risk of certain animal prion diseases, particularly chronic wasting disease.
- The findings underscore the importance of continued surveillance and research into interspecies prion transmission.
- Understanding prion conversion efficiency is crucial for assessing and mitigating public health risks associated with animal prion diseases.
Related Concept Videos
Subviral Agents
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
What is a Species?
Clinical Significance of Antibiotic Resistance
Reservoir of Infection

